Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCT197 for Acute Exacerbations of COPD
NCT02700919Phase 2Completed
- Sponsor
- Mereo BioPharma
- Start
- Aug 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of acumapimod in chronic obstructive pulmonary disease (COPD), sponsored by Mereo BioPharma. Started Aug 2016; status: completed.
02
Drugs
acumapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02700919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700919.